Clinical pathways based on integrative medicine in chinese hospitals improve treatment outcomes for patients with acute myocardial infarction: A multicentre, nonrandomized historically controlled trial

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Wang, Lei ^a,b   Zhang, Minzhou ^a,b   Guo, Liheng ^a,b   Qi, Jianyong ^a,b   Luo, Haiming ^c   He, Hankang ^d   Wang, Xiaolong ^c   Yang, Haiyu ^e   Wu, Yang ^f   Miu, Canming ^g   Chen, Xiaohu ^h   Wu, Jiashin ⁱ  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d Guangxi College Traditional Chinese Medicine   (China)

^e Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji nan University   (China)

^f BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^g ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^h AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

ⁱ UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL PATHWAY; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INTEGRATIVE MEDICINE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 84867786937     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/821641     Document Type: Article

References (23)

1. Yeh R. W., Sidney S., Chandra M., Sorel M., Selby J. V., Go A. S., Population trends in the incidence and outcomes of acute myocardial infarction. The New England Journal of Medicine 2010 362 23 2155 2165 2-s2.0-77953577951 10.1056/NEJMoa0908610
2. Moran A., Gu D., Zhao D., Coxson P., Wang Y. C., Chen C. S., Liu J., Cheng J., Bibbins-Domingo K., Shen Y. M., He J., Goldman L., Future cardiovascular disease in China Markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circulation 2010 3 3 243 252 2-s2.0-77953465659 10.1161/CIRCOUTCOMES.109.910711
3. Gao R., Patel A., Gao W., Hu D., Huang D., Kong L., Qi W., Wu Y., Yang Y., Harris P., Algert C., Groenestein P., Turnbull F., Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart 2008 94 5 554 560 2-s2.0-42549090650 10.1136/hrt.2007.119750 (Pubitemid 351580123)
4. Liu H. X., Wang S. R., Lei Y., Shang J. J., Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction. Journal of Traditional Chinese Medicine 2011 31 4 269 272
5. Shang J. J., Shi H., Zhou Q., Gao W., Liu H. X., A study of prognosis, outcome, and changing tendency of hospitalized AMI patients in Beijing third-grade A-level traditional Chinese medicine hospitals from 1999 to 2008. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 837194 10.1155/2012/837194
6. Every N. R., Hochman J., Becker R., Kopecky S., Cannon C. P., Critical pathways: a review. Circulation 2000 101 4 461 465 2-s2.0-0034141940 (Pubitemid 30067406)
7. Liu J. P., Wang S. C., Wu D. R., Establishment and implementation of evidence-based clinical pathway of Chinese medicine. Zhongguo Zhongxi Jiehe Zazhi 2011 31 1 115 119
8. Bahit M. C., Murphy S. A., Gibson C. M., Cannon C. P., Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry. Critical Pathways in Cardiology 2002 1 2 107 112
9. Wang L., Zhang M. Z., Yang G., Establishment and testing practice of an integrative medical pathway for clinical management of acute myocardial infarction. Zhongguo Zhongxi Jiehe Zazhi 2011 31 1 7 10
10. Zhang J., Zhao X. J., Wang L., Construction and evaluation of integrative medical pathway for acute myocardial infarction. Journal of Clinical Research 2012 28 8 1554 1555
11. Wang L., He J. Z., Zhang J., An approach to law of distribution and evolvement of syndrome elements during peri-reperfusion period on 218 patients with acute myocardial infarction. Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi 2010 17 5 267 269
12. Branch of Cardiovasology of Chinese Association of Integrative Medicine, Traditional Chinese medicine syndrome differentiation standards of coronary heart diseases. Zhongguo Zhong Xi Yi Jie He Za Zhi 1991 11 5 257
13. Chen Y. D., Song X. T., Lv S. Z., Evaluation of various therapies in patients with acute ST segment elevation myocardial infarction who arrived at hospitals within 12 hours from the onset of chest pain. Chinese Journal of Interventional Cardiology 2005 13 1 5 8
14. Antman E. M., Hand M., Armstrong P. W., 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the american college of cardiology/american heart association task force on practice guidelines: developed in collaboration with the canadian cardiovascular society endorsed by the american academy of family physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 2008 117 6 296 329 2-s2.0-43149095124 10.1161/CIRCULATIONAHA.107. 188912
15. Ministry of Health, Clinical pathways of ST-segment elevation myocardial infarction (2009 version). 2009
16. Yip W. C. M., Hsiao W., Meng Q., Chen W., Sun X., Realignment of incentives for health-care providers in China. The Lancet 2010 375 9720 1120 1130 2-s2.0-77949798678 10.1016/S0140-6736(10)60063-3
17. Bahit M. C., Murphy S. A., Gibson C. M., Cannon C. P., Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry. Critical Pathways in Cardiology 2002 1 2 107 112
18. Hu S., Tang S., Liu Y., Zhao Y., Escobar M. L., de Ferranti D., Reform of how health care is paid for in China: challenges and opportunities. The Lancet 2008 372 9652 1846 1853 2-s2.0-56249100014 10.1016/S0140-6736(08)61368-9
19. Bi Y., Gao R., Patel A., Su S., Gao W., Hu D., Huang D., Kong L., Qi W., Wu Y., Yang Y., Turnbull F., Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the clinical pathways for acute coronary syndromes in China (CPACS) study. American Heart Journal 2009 157 3 509 516 2-s2.0-60649116933 10.1016/j.ahj.2008.09.026
20. Liu H. X., Gao W., Zhao D., Shang J. J., Survey on the hospitalization treatment status of acute myocardial infarction patients in 13 hospitals of Western medicine and traditional Chinese medicine in Beijing. Zhonghua Xin Xue Guan Bing Za Zhi 2010 38 4 306 310
21. Gao Z. Y., Xu H., Shi D. Z., Wen C., Liu B. Y., Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. Journal of Ethnopharmacology 2012 141 2 578 583
22. Zhang J. G., Gao D. S., Wei G. H., Clinical study on effect of Astragalus injection on left ventricular remodeling and left ventricular function in patients with acute myocardial infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002 22 5 346 348 2-s2.0-0038810178
23. Zhou R., He L. F., Li Y. J., Shen Y., Chao R. B., Du J. R., Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. Journal of Ethnopharmacology 2012 139 2 440 446